Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Earth Science Tech ( (ETST) ) has provided an announcement.
On November 12, 2025, Earth Science Tech, Inc. announced its financial results for the second fiscal quarter ending September 30, 2025, showcasing significant growth. The company reported a 71.64% year-over-year increase in total assets, reaching $8.66 million, and an 18.48% rise in quarterly net profit to $0.94 million. These results reflect the company’s successful strategy in scaling its businesses and enhancing shareholder value through asset growth and share count reduction.
The most recent analyst rating on (ETST) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Earth Science Tech stock, see the ETST Stock Forecast page.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
Earth Science Tech’s overall stock score is driven by its financial recovery and reasonable valuation. However, technical indicators suggest a bearish trend, which tempers the positive outlook. The lack of dividend yield and past financial instability are additional concerns.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. is a strategic holding company focused on acquiring and scaling high-potential operating businesses. Its operations span various sectors including compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries such as RxCompoundStore.com, Mister Meds, Peaks Curative, and Avenvi, among others.
Average Trading Volume: 70,811
Technical Sentiment Signal: Sell
Current Market Cap: $47.07M
For a thorough assessment of ETST stock, go to TipRanks’ Stock Analysis page.